Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim-supported clozapine rechallenge after clozapine-associated neutropenia
ACTRN12618001830280Phase 2Not yet recruiting
- Sponsor
- The University of Queensland
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of filgrastim and clozapine in schizophrenia, sponsored by The University of Queensland. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
filgrastimclozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ACTRN12618001830280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001830280.